IMM

IMMUNO-ONCOLOGY

Unclaimed Profile

Business overview

IMMUNO-ONCOLOGY (Sole-Proprietor) is an organisation established on 17 Aug 2020 and its current status is
Live
. The organisation is located at 10, UBI CRESCENT, #03-41, UBI TECHPARK, Singapore 408564. The organisation operates in the field of research and experimental development on biotechnology (excluding medical science).
TrustScore
foundational
FDN
IMMUNO-ONCOLOGY
UEN: 53419013L
This profile is unclaimed.

TrustScore Analysis

Our preliminary analysis has revealed key insights about IMMUNO-ONCOLOGY's performance and market presence. Here's a summary of our findings:

Strengths Identified

  • Has been operational for a few years

Areas of Concern

  • No employer brand presence on career platforms
  • May not have contact information online
  • No official business profile found on major search engines

Corporate Information

UEN

53419013L

Entity Type

Sole Proprietorship/ Partnership

Entity Status

Live

ACRA Registration Date

17 Aug 2020

UEN Issue Date

17 Aug 2020

No. of Officers

1

Business Constitution

Sole-Proprietor

Primary Business Activity

Research and experimental development on biotechnology (excluding medical science)

SSIC Code: 72101

IMMUNO-ONCOLOGY's Latest Blogs

Read more about thought leadership articles, industry insights, and official updates directly from IMMUNO-ONCOLOGY's team.

No company blog posts yet

Once posts are published, we will feature the freshest stories from IMMUNO-ONCOLOGY here.

Profile Activity for IMMUNO-ONCOLOGY

Analytics and engagement metrics from recent Scam.SG visitor traffic patterns and profile interactions over the past 14 days.

Trending

Among all Research And Experimental Development On Biotechnology (excluding Medical Science) companies

Low ActivityHigh Activity

Public Preview of IMMUNO-ONCOLOGY

TrustScore analysis is not available for IMMUNO-ONCOLOGY. Showing general band information.

Foundational Stage

A young brand or company in the early stage of organisation structures, framework, processes, workflow, systems.

  • Defining Core Identity: IMMUNO-ONCOLOGY is likely still defining its mission, vision and values.
  • Building Awareness: Working to establish recognition among its target audience and identifying opportunities in the research and experimental development on biotechnology (excluding medical science) sector.
  • Limited Resources: Often operating with a small team, budget, or customer base. May not yet have a strong social media presence or widespread advertising.
  • Focus on Differentiation: Still trying to carve out a unique position in the market, or have a unique selling proposition. They are gathering feedback and iterating on their offerings.
  • These potential brands often represent innovation and creativity.
  • They often bring fresh ideas to the market and have the opportunity to grow into influential players if they successfully establish their identity and connect with their audience.

TrustScore Last Scanned:

10 Nov 2025

IMMUNO-ONCOLOGY Job Openings

Explore available job positions and career opportunities currently offered by IMMUNO-ONCOLOGY.

No Job Openings Available

IMMUNO-ONCOLOGY doesn't have any active job listings at the moment. Check back later for new opportunities.

Check MyCareersFuture
Check LinkedIn
Check JobStreet

Frequently Asked Questions About IMMUNO-ONCOLOGY

Common questions and answers to help you learn more about IMMUNO-ONCOLOGY

IMMUNO-ONCOLOGY has been in operation for 5 years since its incorporation in 17 August 2020 based on ACRA registration date. The business is registered with ACRA (Accounting and Corporate Regulatory Authority) under UEN 53419013L.

Join the Scam.SG community

Share your experience to help others make confident decisions. Follow us for the latest scam prevention tips and community updates.